Australia may be the first country to eliminate cervical cancer, but the inequality remains.

Published Date: 08 Mar 2023

Australia has the potential to become the first country in the world to eliminate cancer as a public health problem.

Read Full News

Latest News

Free Contraception Coverage Curbs Patients’ Costs in BC

Universal contraceptive coverage reduces out-of-pocket costs substantially in British Columbia, especially for young people.

Upcoming Billing Change Could Make Pregnancy Pricier

Under new billing codes starting in January, maternity care doctors will charge à la carte for visits and services related to pregnancy, childbirth, and postpartum care.

Interest in Alternative Menopause Treatments Surging

As menopause has become more visible online, experts see both benefits and risks, from greater patient engagement to the spread of misinformation.

J&J Beats Lawsuit Alleging That Talc Caused Three Women's Cancer

A Los Angeles jury on Friday sided with ⁠Johnson & Johnson in a lawsuit by the families of three women who alleged ⁠that the company's talc products caused ovarian...

FDA Launches Study Of Abortion Pill Safety, WSJ Reports

(Fixes typo in paragraph 6)

Wearable Ultrasound Patch Does Continuous Fetal Monitoring

A skin-mounted ultrasound patch tracks fetal blood flow in real time and may help detect complications in high-risk pregnancies earlier than intermittent scans.

Todays Updates

Multiple Myeloma Patients Have Unequal Access to Treatment

Lack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.

e-Cigarettes and Lung Cancer: Is Harm Reduction Overstated?

A large study links the use of e-cigarettes after smoking cessation to higher lung cancer incidence and mortality than complete nicotine abstinence.

Combination Treatment May Improve Multiple Myeloma Outcomes

Post hoc analysis of the MajesTEC-3 trial shows the efficacy of the teclistamab plus daratumumab combination in hard-to-treat patients with high cytogenetic and functional risk.

Is There a Role for Stimulants in Beating Cancer Fatigue?

Guidelines on treating cancer fatigue offer little enthusiasm for methylphenidate and other stimulants. But a recent meta-analysis suggests the medications deserve a rethink.

Todays Updates

Multiple Myeloma Patients Have Unequal Access to Treatment

Lack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.

e-Cigarettes and Lung Cancer: Is Harm Reduction Overstated?

A large study links the use of e-cigarettes after smoking cessation to higher lung cancer incidence and mortality than complete nicotine abstinence.

Combination Treatment May Improve Multiple Myeloma Outcomes

Post hoc analysis of the MajesTEC-3 trial shows the efficacy of the teclistamab plus daratumumab combination in hard-to-treat patients with high cytogenetic and functional risk.

Is There a Role for Stimulants in Beating Cancer Fatigue?

Guidelines on treating cancer fatigue offer little enthusiasm for methylphenidate and other stimulants. But a recent meta-analysis suggests the medications deserve a rethink.

Latest News

Universal contraceptive coverage reduces out-of-pocket costs substantially in British Columbia, especially for young people.

Under new billing codes starting in January, maternity care doctors will charge à la carte for visits and services related to pregnancy, childbirth, and postpartum care.

As menopause has become more visible online, experts see both benefits and risks, from greater patient engagement to the spread of misinformation.

A Los Angeles jury on Friday sided with ⁠Johnson & Johnson in a lawsuit by the families of three women who alleged ⁠that the company's talc products caused ovarian...

(Fixes typo in paragraph 6)

A skin-mounted ultrasound patch tracks fetal blood flow in real time and may help detect complications in high-risk pregnancies earlier than intermittent scans.

News All Time

Emerging Evidence and Expert Perspectives: Evolving Treatment Strategies in HER2+ Early Breast Cancer

Emerging Evidence and Expert Perspectives: Evolving Treatment Strategies in HER2+ Early Breast Cancer

Scaling Excellence in HER2-Low and -Ultralow Breast Cancer: Real-World Strategies for Testing and Treatment Optimization

Scaling Excellence in HER2-Low and -Ultralow Breast Cancer: Real-World Strategies for Testing and Treatment Optimization

Facing Resistance: Novel Approaches for Endocrine-Resistant HR+/HER2- Breast Cancer

Facing Resistance: Novel Approaches for Endocrine-Resistant HR+/HER2- Breast Cancer

Beyond CLEOPATRA: Integrating Evolving Frontline Maintenance Strategies in HER2+ Metastatic Breast Cancer

Beyond CLEOPATRA: Integrating Evolving Frontline Maintenance Strategies in HER2+ Metastatic Breast Cancer

Powering Up First-Line Treatment in Triple-Negative Breast Cancer: How Antibody-Drug Conjugates and Immune Checkpoint Inhibitors Are Changing the Game

Powering Up First-Line Treatment in Triple-Negative Breast Cancer: How Antibody-Drug Conjugates and Immune Checkpoint Inhibitors Are Changing the Game

Platinum-Resistant Ovarian Cancer (PROC) Office Hours: Translating Clinical Trials Into Clinical Practice for PROC

Platinum-Resistant Ovarian Cancer (PROC) Office Hours: Translating Clinical Trials Into Clinical Practice for PROC

ACOG: American College of Obstetricians and Gynecologists

ASRM: American Society for Reproductive Medicine

SMFM: Society for Maternal-Fetal Medicine

SGO: Society of Gynecologic Oncology

TMS: The Menopause Society

Former UCLA Gynecologist Pleads Guilty to Sex Abuse After Conviction Was Overturned

The plea was unexpected

HHS Changing Its Tune on Contraceptive Access

Focus of Title X program shifting to "natural family planning" and encouragement of pregnancy

High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents

Also from SGO: p53 reactivator active in advanced gynecologic cancers, "perfect" score in GTN

DOJ Fires Prosecutors Accused of Bias Against Anti-Abortion Activists

They are the latest wave of terminations of those involved in cases criticized by conservatives

'Something Is Wrong': Don't Dismiss Pregnant Patients

Bias often shapes whose voices we prioritize and whose we question

Recommended News For You

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

Higher levels of HIF2α found to slow down aggressive childhood cancer

Children with cancer tumors lacking DNA repair may benefit from olaparib combined with ceralasertib.

New analysis helps discern benign from malignant thyroid growths

Lesser-known lobular breast cancer on the rise in U.S. women

Childhood brain tumors develop early in highly specialized nerve cells, research reveals

Recommended Articles For You

Role of Type I Interferons and KDM1B in Driving Cancer Stemness and Therapeutic Evasion 

Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment 

Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies 

Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Five-year survival in patients with unresectable hepatocellular carcinoma sets milestone

2.

Survey: Record Numbers of US Adults Report Depression.

3.

Increased Exercise May Lower the Risk of Prostate Cancer.

4.

Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation

5.

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

1.

Oncolytic Vaccinia Virus Immunotherapy: A New Frontier in GI Cancer Treatment

2.

A Review of Cancer Treatment Evolution Towards Stem Cells and Gene Therapy

3.

The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy

4.

Priming Agents: A Novel Approach to Enhancing Cell-Free DNA Detection in Liquid Biopsies

5.

HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Current Scenario of Cancer- The Incidence of Cancer in Men

2.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

4.

Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.

5.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot